What if the key to diagnosing rare diseases was already in your DNA?
For millions, the journey to a rare disease diagnosis spans years and countless hospital visits, often ending in frustration. But South Korea-based biotech company 3billion is changing that with an innovative solution: AI-powered whole-genome sequencing that delivers answers in minutes, not years. Founded on the belief that clarity can be scaled, 3billion is driving a global shift in rare disease diagnostics, empowering clinicians with faster, more accurate tools, expanding access across 70+ countries, and bridging the gap between sequencing and real-world care.
GeneOnline sat down with CEO Changwon Keum for an exclusive interview, where he shared how 3billion is pushing boundaries in rare disease diagnostics and what’s next for the company. Now setting up shop in the U.S., the company is taking on its biggest challenge yet: navigating insurance, growing partnerships, and even venturing into drug discovery. Behind every genome is a person searching for answers. Discover how 3billion is helping them achieve this. Find the exclusive interview article here!
For millions, the journey to a rare disease diagnosis spans years and countless hospital visits, often ending in frustration. But South Korea-based biotech company 3billion is changing that with an innovative solution: AI-powered whole-genome sequencing that delivers answers in minutes, not years. Founded on the belief that clarity can be scaled, 3billion is driving a global shift in rare disease diagnostics, empowering clinicians with faster, more accurate tools, expanding access across 70+ countries, and bridging the gap between sequencing and real-world care.
GeneOnline sat down with CEO Changwon Keum for an exclusive interview, where he shared how 3billion is pushing boundaries in rare disease diagnostics and what’s next for the company. Now setting up shop in the U.S., the company is taking on its biggest challenge yet: navigating insurance, growing partnerships, and even venturing into drug discovery. Behind every genome is a person searching for answers. Discover how 3billion is helping them achieve this. Find the exclusive interview article here!
0views
